Long-term outcomes after treatment with external beam radiation therapy and palladium 103 for patients with higher risk prostate carcinoma: influence of prostatic acid phosphatase.

Dattoli M, Wallner K, True L, Cash J, Sorace R

Open source

DOI
10.1002/cncr.11154
Published
2003 Feb 15
Container
Cancer
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1002/cncr.11154,
  title = {Long-term outcomes after treatment with external beam radiation therapy and palladium 103 for patients with higher risk prostate carcinoma: influence of prostatic acid phosphatase.},
  author = {Dattoli M and Wallner K and True L and Cash J and Sorace R},
  year = {2003},
  journal = {Cancer},
  doi = {10.1002/cncr.11154},
  url = {https://doi.org/10.1002/cncr.11154}
}

RIS

TY  - JOUR
TI  - Long-term outcomes after treatment with external beam radiation therapy and palladium 103 for patients with higher risk prostate carcinoma: influence of prostatic acid phosphatase.
AU  - Dattoli M
AU  - Wallner K
AU  - True L
AU  - Cash J
AU  - Sorace R
PY  - 2003
JO  - Cancer
DO  - 10.1002/cncr.11154
UR  - https://doi.org/10.1002/cncr.11154
ER  - 

APA

M, D., K, W., L, T., J, C., & R, S. (2003). Long-term outcomes after treatment with external beam radiation therapy and palladium 103 for patients with higher risk prostate carcinoma: influence of prostatic acid phosphatase.. Cancer. https://doi.org/10.1002/cncr.11154

Source records